Impact of COVID-19 Outbreak on Meningococcal Vaccination, Global Market Research Report 2020

July 2020 | 96 pages | ID: I23AB5823870EN
QYResearch

Abstracts

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Meningococcal Vaccination market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyzes the impact of Coronavirus COVID-19 on the Meningococcal Vaccination industry.

Segment by Type, the Meningococcal Vaccination market is segmented into

• Polysaccharide
• Conjugate
• Combination

Segment by Application

• Pneumonia
• Meningitis
• Bacteremia
• Others

Global Meningococcal Vaccination Market: Regional Analysis
The Meningococcal Vaccination market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Meningococcal Vaccination market report are:

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE

Global Meningococcal Vaccination Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Meningococcal Vaccination market include:

• GlaxoSmithKline
• JN-International Medical
• Novartis International
• Sanofi
• Pfizer
• Baxter International
• Biomed
• Serum Institute of India

Contents

1 MENINGOCOCCAL VACCINATION MARKET OVERVIEW

1.1 Product Overview and Scope of Meningococcal Vaccination
1.2 Covid-19 Impact on Meningococcal Vaccination Segment by Type
  1.2.1 Global Meningococcal Vaccination Sales Growth Rate Comparison by Type (2021-2026)
  1.2.2 Polysaccharide
  1.2.3 Conjugate
  1.2.4 Combination
1.3 Covid-19 Impact on Meningococcal Vaccination Segment by Application
  1.3.1 Meningococcal Vaccination Sales Comparison by Application: 2020 VS 2026
  1.3.2 Pneumonia
  1.3.3 Meningitis
  1.3.4 Bacteremia
  1.3.5 Others
1.4 Covid-19 Impact on Global Meningococcal Vaccination Market Size Estimates and Forecasts
  1.4.1 Global Meningococcal Vaccination Revenue 2015-2026
  1.4.2 Global Meningococcal Vaccination Sales 2015-2026
  1.4.3 Meningococcal Vaccination Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.5.2 Covid-19 Impact: Commodity Prices Indices
  1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Meningococcal Vaccination Industry
1.7 COVID-19 Impact: Meningococcal Vaccination Market Trends

2 COVID-19 IMPACT ON GLOBAL MENINGOCOCCAL VACCINATION MARKET COMPETITION BY MANUFACTURERS

2.1 Global Meningococcal Vaccination Sales Market Share by Manufacturers (2015-2020)
2.2 Global Meningococcal Vaccination Revenue Share by Manufacturers (2015-2020)
2.3 Global Meningococcal Vaccination Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Meningococcal Vaccination Manufacturing Sites, Area Served, Product Type
2.5 Meningococcal Vaccination Market Competitive Situation and Trends
  2.5.1 Meningococcal Vaccination Market Concentration Rate
  2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Meningococcal Vaccination Players (Opinion Leaders)

3 COVID-19 IMPACT ON MENINGOCOCCAL VACCINATION RETROSPECTIVE MARKET SCENARIO BY REGION

3.1 Global Meningococcal Vaccination Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Meningococcal Vaccination Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Meningococcal Vaccination Market Facts & Figures by Country
  3.3.1 North America Meningococcal Vaccination Sales by Country
  3.3.2 North America Meningococcal Vaccination Sales by Country
  3.3.3 U.S.
  3.3.4 Canada
3.4 Europe Meningococcal Vaccination Market Facts & Figures by Country
  3.4.1 Europe Meningococcal Vaccination Sales by Country
  3.4.2 Europe Meningococcal Vaccination Sales by Country
  3.4.3 Germany
  3.4.4 France
  3.4.5 U.K.
  3.4.6 Italy
  3.4.7 Russia
3.5 Asia Pacific Meningococcal Vaccination Market Facts & Figures by Region
  3.5.1 Asia Pacific Meningococcal Vaccination Sales by Region
  3.5.2 Asia Pacific Meningococcal Vaccination Sales by Region
  3.5.3 China
  3.5.4 Japan
  3.5.5 South Korea
  3.5.6 India
  3.5.7 Australia
  3.5.8 Taiwan
  3.5.9 Indonesia
  3.5.10 Thailand
  3.5.11 Malaysia
  3.5.12 Philippines
  3.5.13 Vietnam
3.6 Latin America Meningococcal Vaccination Market Facts & Figures by Country
  3.6.1 Latin America Meningococcal Vaccination Sales by Country
  3.6.2 Latin America Meningococcal Vaccination Sales by Country
  3.6.3 Mexico
  3.6.3 Brazil
  3.6.3 Argentina
3.7 Middle East and Africa Meningococcal Vaccination Market Facts & Figures by Country
  3.7.1 Middle East and Africa Meningococcal Vaccination Sales by Country
  3.7.2 Middle East and Africa Meningococcal Vaccination Sales by Country
  3.7.3 Turkey
  3.7.4 Saudi Arabia
  3.7.5 UAE

4 COVID-19 IMPACT ON GLOBAL MENINGOCOCCAL VACCINATION HISTORIC MARKET ANALYSIS BY TYPE

4.1 Global Meningococcal Vaccination Sales Market Share by Type (2015-2020)
4.2 Global Meningococcal Vaccination Revenue Market Share by Type (2015-2020)
4.3 Global Meningococcal Vaccination Price Market Share by Type (2015-2020)
4.4 Global Meningococcal Vaccination Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 COVID-19 IMPACT ON GLOBAL MENINGOCOCCAL VACCINATION HISTORIC MARKET ANALYSIS BY APPLICATION

5.1 Global Meningococcal Vaccination Sales Market Share by Application (2015-2020)
5.2 Global Meningococcal Vaccination Revenue Market Share by Application (2015-2020)
5.3 Global Meningococcal Vaccination Price by Application (2015-2020)

6 COMPANY PROFILES AND KEY FIGURES IN MENINGOCOCCAL VACCINATION BUSINESS

6.1 GlaxoSmithKline
  6.1.1 Corporation Information
  6.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
  6.1.3 GlaxoSmithKline Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  6.1.4 GlaxoSmithKline Products Offered
  6.1.5 GlaxoSmithKline Recent Development and Response to COVID-19
6.2 JN-International Medical
  6.2.1 JN-International Medical Corporation Information
  6.2.2 JN-International Medical Description, Business Overview and Total Revenue
  6.2.3 JN-International Medical Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  6.2.4 JN-International Medical Products Offered
  6.2.5 JN-International Medical Recent Development and Response to COVID-19
6.3 Novartis International
  6.3.1 Novartis International Corporation Information
  6.3.2 Novartis International Description, Business Overview and Total Revenue
  6.3.3 Novartis International Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  6.3.4 Novartis International Products Offered
  6.3.5 Novartis International Recent Development and Response to COVID-19
6.4 Sanofi
  6.4.1 Sanofi Corporation Information
  6.4.2 Sanofi Description, Business Overview and Total Revenue
  6.4.3 Sanofi Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Sanofi Products Offered
  6.4.5 Sanofi Recent Development and Response to COVID-19
6.5 Pfizer
  6.5.1 Pfizer Corporation Information
  6.5.2 Pfizer Description, Business Overview and Total Revenue
  6.5.3 Pfizer Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  6.5.4 Pfizer Products Offered
  6.5.5 Pfizer Recent Development and Response to COVID-19
6.6 Baxter International
  6.6.1 Baxter International Corporation Information
  6.6.2 Baxter International Description, Business Overview and Total Revenue
  6.6.3 Baxter International Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  6.6.4 Baxter International Products Offered
  6.6.5 Baxter International Recent Development and Response to COVID-19
6.7 Biomed
  6.6.1 Biomed Corporation Information
  6.6.2 Biomed Description, Business Overview and Total Revenue
  6.6.3 Biomed Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Biomed Products Offered
  6.7.5 Biomed Recent Development and Response to COVID-19
6.8 Serum Institute of India
  6.8.1 Serum Institute of India Corporation Information
  6.8.2 Serum Institute of India Description, Business Overview and Total Revenue
  6.8.3 Serum Institute of India Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
  6.8.4 Serum Institute of India Products Offered
  6.8.5 Serum Institute of India Recent Development and Response to COVID-19

7 MENINGOCOCCAL VACCINATION MANUFACTURING COST ANALYSIS

7.1 Meningococcal Vaccination Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Key Raw Materials Price Trend
  7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Meningococcal Vaccination
7.4 Meningococcal Vaccination Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

8.1 Marketing Channel
8.2 Meningococcal Vaccination Distributors List
8.3 Meningococcal Vaccination Customers

9 MARKET DYNAMICS

9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

10.1 Global Meningococcal Vaccination Market Estimates and Projections by Type
  10.1.1 Global Forecasted Sales of Meningococcal Vaccination by Type (2021-2026)
  10.1.2 Global Forecasted Revenue of Meningococcal Vaccination by Type (2021-2026)
10.2 Meningococcal Vaccination Market Estimates and Projections by Application
  10.2.1 Global Forecasted Sales of Meningococcal Vaccination by Application (2021-2026)
  10.2.2 Global Forecasted Revenue of Meningococcal Vaccination by Application (2021-2026)
10.3 Meningococcal Vaccination Market Estimates and Projections by Region
  10.3.1 Global Forecasted Sales of Meningococcal Vaccination by Region (2021-2026)
  10.3.2 Global Forecasted Revenue of Meningococcal Vaccination by Region (2021-2026)
10.4 North America Meningococcal Vaccination Estimates and Projections (2021-2026)
10.5 Europe Meningococcal Vaccination Estimates and Projections (2021-2026)
10.6 Asia Pacific Meningococcal Vaccination Estimates and Projections (2021-2026)
10.7 Latin America Meningococcal Vaccination Estimates and Projections (2021-2026)
10.8 Middle East and Africa Meningococcal Vaccination Estimates and Projections (2021-2026)

11 RESEARCH FINDING AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Meningococcal Vaccination Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Meningococcal Vaccination Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Meningococcal Vaccination Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Meningococcal Vaccination Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Meningococcal Vaccination Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Meningococcal Vaccination Players to Combat Covid-19 Impact
Table 9. Global Key Meningococcal Vaccination Manufacturers Covered in This Study
Table 10. Global Meningococcal Vaccination Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Meningococcal Vaccination Sales Share by Manufacturers (2015-2020)
Table 12. Global Meningococcal Vaccination Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Meningococcal Vaccination Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Meningococcal Vaccination Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Meningococcal Vaccination Sales Sites and Area Served
Table 16. Manufacturers Meningococcal Vaccination Product Types
Table 17. Global Meningococcal Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Meningococcal Vaccination by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccination as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Meningococcal Vaccination Players
Table 21. Global Meningococcal Vaccination Sales (K Units) by Region (2015-2020)
Table 22. Global Meningococcal Vaccination Sales Market Share by Region (2015-2020)
Table 23. Global Meningococcal Vaccination Revenue (Million US$) by Region (2015-2020)
Table 24. Global Meningococcal Vaccination Revenue Market Share by Region (2015-2020)
Table 25. North America Meningococcal Vaccination Sales by Country (2015-2020) (K Units)
Table 26. North America Meningococcal Vaccination Sales Market Share by Country (2015-2020)
Table 27. North America Meningococcal Vaccination Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Meningococcal Vaccination Revenue Market Share by Country (2015-2020)
Table 29. Europe Meningococcal Vaccination Sales by Country (2015-2020) (K Units)
Table 30. Europe Meningococcal Vaccination Sales Market Share by Country (2015-2020)
Table 31. Europe Meningococcal Vaccination Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Meningococcal Vaccination Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Meningococcal Vaccination Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Meningococcal Vaccination Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Meningococcal Vaccination Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Meningococcal Vaccination Revenue Market Share by Region (2015-2020)
Table 37. Latin America Meningococcal Vaccination Sales by Country (2015-2020) (K Units)
Table 38. Latin America Meningococcal Vaccination Sales Market Share by Country (2015-2020)
Table 39. Latin America Meningococcal Vaccination Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Meningococcal Vaccination Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Meningococcal Vaccination Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Meningococcal Vaccination Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Meningococcal Vaccination Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Meningococcal Vaccination Revenue Market Share by Country (2015-2020)
Table 45. Global Meningococcal Vaccination Sales (K Units) by Type (2015-2020)
Table 46. Global Meningococcal Vaccination Sales Share by Type (2015-2020)
Table 47. Global Meningococcal Vaccination Revenue (Million US$) by Type (2015-2020)
Table 48. Global Meningococcal Vaccination Revenue Share by Type (2015-2020)
Table 49. Global Meningococcal Vaccination Price (US$/Unit) by Type (2015-2020)
Table 50. Global Meningococcal Vaccination Sales (K Units) by Application (2015-2020)
Table 51. Global Meningococcal Vaccination Sales Market Share by Application (2015-2020)
Table 52. Global Meningococcal Vaccination Sales Growth Rate by Application (2015-2020)
Table 53. GlaxoSmithKline Meningococcal Vaccination Corporation Information
Table 54. GlaxoSmithKline Description and Business Overview
Table 55. GlaxoSmithKline Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. GlaxoSmithKline Main Product
Table 57. GlaxoSmithKline Recent Development
Table 58. JN-International Medical Meningococcal Vaccination Corporation Information
Table 59. JN-International Medical Corporation Information
Table 60. JN-International Medical Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. JN-International Medical Main Product
Table 62. JN-International Medical Recent Development
Table 63. Novartis International Meningococcal Vaccination Corporation Information
Table 64. Novartis International Corporation Information
Table 65. Novartis International Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Novartis International Main Product
Table 67. Novartis International Recent Development
Table 68. Sanofi Meningococcal Vaccination Corporation Information
Table 69. Sanofi Corporation Information
Table 70. Sanofi Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Sanofi Main Product
Table 72. Sanofi Recent Development
Table 73. Pfizer Meningococcal Vaccination Corporation Information
Table 74. Pfizer Corporation Information
Table 75. Pfizer Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Pfizer Main Product
Table 77. Pfizer Recent Development
Table 78. Baxter International Meningococcal Vaccination Corporation Information
Table 79. Baxter International Corporation Information
Table 80. Baxter International Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Baxter International Main Product
Table 82. Baxter International Recent Development
Table 83. Biomed Meningococcal Vaccination Corporation Information
Table 84. Biomed Corporation Information
Table 85. Biomed Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. Biomed Main Product
Table 87. Biomed Recent Development
Table 88. Serum Institute of India Meningococcal Vaccination Corporation Information
Table 89. Serum Institute of India Corporation Information
Table 90. Serum Institute of India Meningococcal Vaccination Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 91. Serum Institute of India Main Product
Table 92. Serum Institute of India Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Meningococcal Vaccination Distributors List
Table 96. Meningococcal Vaccination Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Meningococcal Vaccination Sales (K Units) Forecast by Type (2021-2026)
Table 101. Global Meningococcal Vaccination Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Meningococcal Vaccination Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Meningococcal Vaccination Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Meningococcal Vaccination Sales (K Units) Forecast by Application (2021-2026)
Table 105. Global Meningococcal Vaccination Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Meningococcal Vaccination Sales (K Units) Forecast by Region (2021-2026)
Table 107. Global Meningococcal Vaccination Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Meningococcal Vaccination Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Meningococcal Vaccination Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Meningococcal Vaccination
Figure 2. Global Meningococcal Vaccination Sales Market Share by Type: 2020 VS 2026
Figure 3. Polysaccharide Product Picture
Figure 4. Conjugate Product Picture
Figure 5. Combination Product Picture
Figure 6. Global Meningococcal Vaccination Consumption Market Share by Application: 2020 VS 2026
Figure 7. Pneumonia
Figure 8. Meningitis
Figure 9. Bacteremia
Figure 10. Others
Figure 11. Global Meningococcal Vaccination Market Size 2015-2026 (US$ Million)
Figure 12. Global Meningococcal Vaccination Sales Capacity (K Units) (2015-2026)
Figure 13. Global Meningococcal Vaccination Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Meningococcal Vaccination Sales Share by Manufacturers in 2020
Figure 15. Global Meningococcal Vaccination Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Meningococcal Vaccination Revenue in 2019
Figure 17. Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Meningococcal Vaccination Sales Market Share by Region (2015-2020)
Figure 19. Global Meningococcal Vaccination Sales Market Share by Region in 2019
Figure 20. Global Meningococcal Vaccination Revenue Market Share by Region (2015-2020)
Figure 21. Global Meningococcal Vaccination Revenue Market Share by Region in 2019
Figure 22. North America Meningococcal Vaccination Sales Market Share by Country in 2019
Figure 23. North America Meningococcal Vaccination Revenue Market Share by Country in 2019
Figure 24. U.S. Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 25. U.S. Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Meningococcal Vaccination Sales Market Share by Country in 2019
Figure 29. Europe Meningococcal Vaccination Revenue Market Share by Country in 2019
Figure 30. Germany Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 31. Germany Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 37. Italy Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 39. Russia Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Meningococcal Vaccination Sales Market Share by Region in 2019
Figure 41. Asia Pacific Meningococcal Vaccination Revenue Market Share by Region in 2019
Figure 42. China Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 43. China Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 45. Japan Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 49. India Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 51. Australia Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 57. Thailand Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 59. Malaysia Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 61. Philippines Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 63. Vietnam Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Meningococcal Vaccination Sales Market Share by Country in 2019
Figure 65. Latin America Meningococcal Vaccination Revenue Market Share by Country in 2019
Figure 66. Mexico Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 67. Mexico Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 69. Brazil Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Meningococcal Vaccination Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Meningococcal Vaccination Revenue Market Share by Country in 2019
Figure 74. Turkey Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 75. Turkey Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 77. Saudi Arabia Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. UAE Meningococcal Vaccination Sales Growth Rate (2015-2020) (K Units)
Figure 79. UAE Meningococcal Vaccination Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Meningococcal Vaccination by Type (2015-2020)
Figure 81. Sales Market Share of Meningococcal Vaccination by Type in 2019
Figure 82. Revenue Share of Meningococcal Vaccination by Type (2015-2020)
Figure 83. Revenue Market Share of Meningococcal Vaccination by Type in 2019
Figure 84. Global Meningococcal Vaccination Sales Growth by Type (2015-2020) (K Units)
Figure 85. Global Meningococcal Vaccination Sales Market Share by Application (2015-2020)
Figure 86. Global Meningococcal Vaccination Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Meningococcal Vaccination by Application (2015-2020)
Figure 88. Global Revenue Share of Meningococcal Vaccination by Application in 2020
Figure 89. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. JN-International Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Novartis International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Baxter International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Biomed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Price Trend of Key Raw Materials
Figure 98. Manufacturing Cost Structure of Meningococcal Vaccination
Figure 99. Manufacturing Process Analysis of Meningococcal Vaccination
Figure 100. Meningococcal Vaccination Industrial Chain Analysis
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. North America Meningococcal Vaccination Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. North America Meningococcal Vaccination Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Meningococcal Vaccination Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Meningococcal Vaccination Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Meningococcal Vaccination Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Meningococcal Vaccination Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Meningococcal Vaccination Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Meningococcal Vaccination Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Meningococcal Vaccination Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Meningococcal Vaccination Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed